Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

Abroad (travel likely)Recruiting

Conditions

Cervical Carcinoma · Human Papillomavirus Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Warner K. Huh) · whuh@uabmc.edu
    Contact: Principal Investigator (Warner K. Huh)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Lisa C. Flowers) · lflowe2@emory.edu
    Contact: Principal Investigator (Lisa C. Flowers)
  • Louisiana State University, Lafayette, Louisiana, United States

    Contact: Study coordinator (Michael E. Hagensee) · mhagen@lsuhsc.edu
    Contact: Principal Investigator (Michael E. Hagensee)
  • Louisiana State University Health Science Center, New Orleans, Louisiana, United States

    Contact: Study coordinator (Michael E. Hagensee) · mhagen@lsuhsc.edu
    Contact: Principal Investigator (Michael E. Hagensee)
  • Minneapolis VA Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Elisheva Danan) · elizabeth.danan@va.gov
    Contact: Principal Investigator (Elisheva Danan)
  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Cosette M. Wheeler) · cwheeler@salud.unm.edu
    Contact: Principal Investigator (Cosette M. Wheeler)
  • Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States

    Contact: Study coordinator (Mark H. Einstein) · meinstei@montefiore.org
    Contact: Principal Investigator (Mark H. Einstein)
  • Montefiore Medical Center-Weiler Hospital, The Bronx, New York, United States

    Contact: Study coordinator (Mark H. Einstein) · meinstei@montefiore.org
    Contact: Principal Investigator (Mark H. Einstein)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Lisa Rahangdale) · lisa_rahangdale@med.unc.edu
    Contact: Principal Investigator (Lisa Rahangdale)
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Leeya F. Pinder) · pinderl@ucmail.uc.edu
    Contact: Principal Investigator (Leeya F. Pinder)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Jacqueline A. Bohn) · jacqueline-bohn@ouhsc.edu
    Contact: Principal Investigator (Jacqueline A. Bohn)
  • University of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Jacqueline A. Bohn) · jacqueline-bohn@ou.edu
    Contact: Principal Investigator (Jacqueline A. Bohn)
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Carmen Guerra) · cguerra@pennmedicine.upenn.edu
    Contact: Principal Investigator (Carmen Guerra)
  • UPMC-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Harold C. Wiesenfeld) · wieshc@upmc.edu
    Contact: Principal Investigator (Harold C. Wiesenfeld)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Harold C. Wiesenfeld) · wieshc@upmc.edu
    Contact: Principal Investigator (Harold C. Wiesenfeld)
  • UT MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Elizabeth Y. Chiao) · eychiao@mdanderson.org
    Contact: Principal Investigator (Elizabeth Y. Chiao)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Deanna L. Kepka) · deanna.kepka@hci.utah.edu
    Contact: Principal Investigator (Deanna L. Kepka)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Krista S. Pfaendler) · krista.pfaendler@hsc.wvu.edu
    Contact: Principal Investigator (Krista S. Pfaendler)
Study leads
  • Vikrant V Sahasrabuddhe

    Principal Investigator

    National Cancer Institute Division of Cancer Prevention